Officials say the Army has reenlisted more than 23 soldiers who were discharged for refusing the COVID-19 vaccine.

Mass firings at the FDA have decimated divisions tasked with releasing public records generated by the agency's regulatory ...

The COVID-19 vaccine continues to save lives, proving the vaccination strategy paid off and was a worthwhile national ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Pfizer faces growth challenges with patent losses and waning COVID sales. Selling an ATM Put option expiring Nov'25 could ...

(Reuters) -Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services ...

Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

PFE stock is likely to be a great pick for value investors, considering its cheap valuation, as well as for income investors ...

Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID shot approval delay.

Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new pandemic surged around them. By a year later, 66 million American adults had ...

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...